Pennovation Works, a 23-acre property owned by the University of Pennsylvania on the Schuylkill River from the main campus, has long been a center of innovation. 19th century headquarters of a ferry business. a painting company in the 20th century. For much of the 20th century a DuPont chemical research facility, the space underwent another transformation in 2016, when the Pennovation Center was created, the incubator. science and technology startups, many of which originate at the University. Last year, the 65,000-square-foot Pennovation Lab was opened, offering larger laboratory space to companies growing in previous locations.
Now the next phase of re-imagining this site will begin.
With a 75-year lease of land, Longfellow Real Estate Partners will develop, fund and operate a 455,000-square-foot life sciences facility on 34th Street and Grays Ferry Avenue. The building will have approximately 387,000 square feet for biological research and development and 68,000 square feet for biomanufacturing. Construction of the building, to visually integrate with the structures of the Pennovation Works campus designed by the Jacobs architecture firm, is scheduled to begin next year, with a planned opening for 2025.
With Penn’s prolific cell and gene therapy programs, as well as mRNA’s success and therapeutic promise for the future, labs and biofabrication facilities will provide an opportunity for biotechnology companies to continue expanding in Philadelphia, next to Penn’s campus. .
To learn more about the project, the evolution of Pennovation Works, and the growing ecosystem of life sciences in Philadelphia, Penn Today Craig Carnaroli spoke with Penn’s vice president. Carnaroli served as Vice President of Finance from 2000 to 2004 and has been Executive Vice President since 2004. The campus has been adapting extensively to this role, including Pennovation Works, since it was acquired in 2010.